Cited by 395

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.

Radiometals for Combined Imaging and Therapy

Cutler, Cathy S., Hennkens, Heather M., Sisay, Nebiat, Huclier-Markai, Sandrine, Jurisson, Silvia S.·2013·Chemical Reviews

DOI 10.1021/cr3003104

Open this paper in CoChat — free account

Abstract

ADVERTISEMENT RETURN TO ISSUEPREVReviewNEXTRadiometals for Combined Imaging and TherapyCathy S. Cutler*†, Heather M. Hennkens†, Nebiat Sisay†‡, Sandrine Huclier-Markai§, and Silvia S. Jurisson‡View Author Information† University of Missouri Research Reactor Center, Columbia, Missouri 65211, United States‡ Department of Chemistry, University of Missouri, Columbia, Missouri 65211, United States§ Laboratoire Subatech, UMR 6457, Ecole des Mines de Nantes/Université de Nantes/CNRS-IN2P3, 4 Rue A. Kastler, BP 20722, F-44307 Nantes Cedex 3, FranceCite this: Chem. Rev. 2013, 113, 2, 858–883Publication Date (Web):November 30, 2012Publication History Received1 August 2012Published online30 November 2012Published inissue 13 February 2013https://pubs.acs.org/doi/10.1021/cr3003104https://doi.org/10.1021/cr3003104review-articleACS PublicationsCopyright © 2012 American Chemical SocietyRequest reuse permissionsArticle Views7031Altmetric-Citations317LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Anatomy,Cancer,Cancer therapy,Peptides and proteins,Tumors Get e-Alerts

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1021/cr3003104

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides
Shannon, R. D. (1976) · Acta Crystallographica Section A · doi:10.1107/s0567739476001551 · Cited by 66,145
Holland‐Frei Cancer Medicine
(2016) · Wiley eBooks · doi:10.1002/9781119000822 · Cited by 1,148
Strategies to improve radiotherapy with targeted drugs
Begg, A. C., Stewart, F. A., & Vens, C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3007 · Cited by 1,118
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
Wadas, T. J., Wong, E. H., Weisman, G. R., & Anderson, C. J. (2010) · Chemical Reviews · doi:10.1021/cr900325h · Cited by 924
Lanthanide and Actinide Chemistry
Cotton, S. (2006) · Wiley eBooks · doi:10.1002/0470010088 · Cited by 901
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
Dijkers, E. C., Oude Munnink, T. H., Kosterink, J. G., Brouwers, A. H., Jager, P. L., de Jong, J. R., van Dongen, G. A., Schröder, C. P., Lub-de Hooge, M. N., & de Vries, E. G. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.12 · Cited by 805
A receptor for green tea polyphenol EGCG
Tachibana, H., Koga, K., Fujimura, Y., & Yamada, K. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb743 · Cited by 679
Coordination compounds in nuclear medicine
Jurisson, S. S., Berning, D. E., Jia, W. P., & Ma, D. (1993) · Chemical Reviews · doi:10.1021/cr00019a013 · Cited by 565
Self-citation
Phase I Trial of 177Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer
Bander, N. H., Milowsky, M. I., Nanus, D. M., Kostakoglu, L., Vallabhajosula, S., & Goldsmith, S. J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.160 · Cited by 509
Targeted α particle immunotherapy for myeloid leukemia
Jurcic, J. G., Larson, S. M., Sgouros, G., McDevitt, M. R., Finn, R. D., Divgi, C. R., Ballangrud, Å. M., Hamacher, K. A., Ma, D., Humm, J. L., et al. (2002) · Blood · doi:10.1182/blood.v100.4.1233.h81602001233_1233_1239 · Cited by 472
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
Waldherr, C., Pless, M., Maëcke, H. R., Schumacher, T., Crazzolara, A., Nitzsche, E. U., Haldemann, A. R., & Mueller‐Brand, J. (2002) · PubMed · Cited by 445
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
Liu, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.006 · Cited by 420
Biocoordination chemistry of bismuth: Recent advances
YANG, N., & SUN, H. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.03.003 · Cited by 319
In Vivo Transchelation of Copper-64 from TETA-Octreotide to Superoxide Dismutase in Rat Liver
Bass, L. A., Wang, M., Welch, M. J., & Anderson, C. J. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990167l · Cited by 311
Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships
Dearling, J. L. J., Lewis, J. S., Mullen, G. E. D., Welch, M. J., & Blower, P. J. (2002) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750100291 · Cited by 277
Laminin receptor specific therapeutic gold nanoparticles ( 198 AuNP-EGCg) show efficacy in treating prostate cancer
Shukla, R., Chanda, N., Zambre, A., Upendran, A., Katti, K., Kulkarni, R. R., Nune, S. K., Casteel, S. W., Smith, C. J., Vimal, J., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121174109 · Cited by 273
Self-citation
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Anderson, C. J., Dehdashti, F., Cutler, P. D., Schwarz, S. W., Laforest, R. A., Bass, L. A., Lewis, J. S., & Mccarthy, D. W. (2001) · PubMed · Cited by 273
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
McDevitt, M. R., Barendswaard, E., Ma, D., Lai, L. T., Curcio, M. J., Sgouros, G., Ballangrud, Å., Yang, W., Finn, R. D., Pellegrini, V., et al. (2000) · PubMed · Cited by 259
Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen, X. S., Hou, Y., Tohme, M. S., Park, R. J.-H., Khankaldyyan, V., Gonzales-Gomez, I., Bading, J. R., Laug, W. E., & Conti, P. S. (2004) · PubMed · Cited by 254
Samarium-153-EDTMP biodistribution and dosimetry estimation.
Eary, J. F., Collins, C., Stabin, M., Vernon, C. B., Petersdorf, S. H., Baker, M., Hartnett, S. D., Ferency, S., Addison, S. J., & Appelbaum, F. R. (1993) · PubMed · Cited by 225
An Assessment of the Effects of Shell Cross-Linked Nanoparticle Size, Core Composition, and Surface PEGylation on in Vivo Biodistribution
Sun, X., Rossin, R., Turner, J. L., Becker, M. L., Joralemon, M. J., Welch, M. J., & Wooley, K. L. (2005) · Biomacromolecules · doi:10.1021/bm050260e · Cited by 223
Comparison of 64Cu-Complexing Bifunctional Chelators for Radioimmunoconjugation: Labeling Efficiency, Specific Activity, and in Vitro/in Vivo Stability
Cooper, M. S., Ma, M. T., Sunassee, K., Shaw, K. P., Williams, J. D., Paul, R. L., Donnelly, P. S., & Blower, P. J. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300037w · Cited by 217
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment
Wu, A. M., Yazaki, P. J., Tsai, S.-W., Nguyen, K., Anderson, A.-L., McCarthy, D. W., Welch, M. J., Shively, J. E., Williams, L. E., Raubitschek, A. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150228297 · Cited by 214
Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours
Mansi, R., Wang, X., Forrer, F., Waser, B., Cescato, R., Graham, K., Borkowski, S., Reubi, J. C., & Maecke, H. R. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1596-9 · Cited by 205
The low-energy β− and electron emitter 161Tb as an alternative to 177Lu for targeted radionuclide therapy
Lehenberger, S., Barkhausen, C., Cohrs, S., Fischer, E., Grünberg, J., Hohn, A., Köster, U., Schibli, R., Türler, A., & Zhernosekov, K. (2011) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2011.02.007 · Cited by 200
Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy.
Kozak, R. W., Atcher, R. W., Gansow, O. A., Friedman, A. M., Hines, J. J., & Waldmann, T. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.2.474 · Cited by 197
Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.
Lewis, J. S., Sharp, T. L., Laforest, R. A., Fujibayashi, Y., & Welch, M. J. (2001) · PubMed · Cited by 187
Alpha-emitting bismuth cyclohexylbenzyl DTPA constructs of recombinant humanized anti-CD33 antibodies: pharmacokinetics, bioactivity, toxicity and chemistry.
Nikula, T. K., McDevitt, M. R., Finn, R. D., Wu, C., Kozak, R. W., Garmestani, K., Brechbiel, M. W., Curcio, M. J., Pippin, C. G., Tiffany-Jones, L., et al. (1999) · PubMed · Cited by 176
Phase II Trial of Consolidation Docetaxel and Samarium-153 in Patients With Bone Metastases From Castration-Resistant Prostate Cancer
Fizazi, K., Beuzeboc, P., Lumbroso, J., Haddad, V., Massard, C., Gross-Goupil, M., Di Palma, M., Escudier, B., Theodore, C., Loriot, Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.9811 · Cited by 173
Cancer radioimmunotherapy with alpha-emitting nuclides
Couturier, O., Supiot, S., Degraef-Mougin, M., Faivre-Chauvet, A., Carlier, T., Chatal, J.-F., Davodeau, F., & Cherel, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1803-2 · Cited by 170
Structural Variations Across the Lanthanide Series of Macrocyclic DOTA Complexes: Insights into the Design of Contrast Agents for Magnetic Resonance Imaging
Benetollo, F., Bombieri, G., Calabi, L., Aime, S., & Botta, M. (2002) · Inorganic Chemistry · doi:10.1021/ic025790n · Cited by 166
Bismuth(III) complexes with aminopolycarboxylate and polyaminopolycarboxylate ligands: Chemistry and structure
Stavila, V., Davidovich, R. L., Gulea, A., & Whitmire, K. H. (2006) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.02.032 · Cited by 162
64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation.
Rossin, R., Pan, D., Qi, K., Turner, J. L., Sun, X., Wooley, K. L., & Welch, M. J. (2005) · PubMed · Cited by 161
Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”
Brans, B., Bodei, L., Giammarile, F., Linden, O., Luster, M., Oyen, W. J. G., & Tennvall, J. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0338-5 · Cited by 158
Preparation and Biological Evaluation of Copper-64–Labeled Tyr3-Octreotate Using a Cross-Bridged Macrocyclic Chelator
Sprague, J. E., Peng, Y., Sun, X., Weisman, G. R., Wong, E. H., Achilefu, S., & Anderson, C. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1084 · Cited by 158
Coordination of lanthanides by two polyamino polycarboxylic macrocycles: formation of highly stable lanthanide complexes
Loncin, M. F., Desreux, J. F., & Merciny, E. (1986) · Inorganic Chemistry · doi:10.1021/ic00235a031 · Cited by 157
Systemic Metabolic Radiopharmaceutical Therapy in the Treatment of Metastatic Bone Pain
Paes, F. M., & Serafini, A. N. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2009.10.003 · Cited by 155
The Chemical Fate of 212Bi-DOTA Formed by β- Decay of 212Pb(DOTA)2-***
Mirzadeh, S., Kumar, K., & Gansow, O. A. (1993) · Radiochimica Acta · doi:10.1524/ract.1993.60.1.1 · Cited by 155
Alpha-particles for targeted therapy
Sgouros, G. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.007 · Cited by 153
Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo.
Zuckier, L. S., Dohán, O., Li, Y., Chang, C., Carrasco, N., Dadachova, E., & Dohan, O. (2004) · PubMed · Cited by 142
An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation.
McDevitt, M. R., Finn, R. D., Sgouros, G., Ma, D., & Scheinberg, D. A. (1999) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(98)00151-1 · Cited by 138
A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
Turner, J. H., Claringbold, P. G., Hetherington, E. L. R., Sorby, P. J., & Martindale, A. A. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.12.1926 · Cited by 137
The Development of the α-Particle Emitting Radionuclides 212Bi and 213Bi, and Their Decay Chain Related Radionuclides, for Therapeutic Applications
Hassfjell, S. P., & Brechbiel, M. W. (2001) · Chemical Reviews · doi:10.1021/cr000118y · Cited by 135
Peptides and Receptors in Image-Guided Therapy: Theranostics for Neuroendocrine Neoplasms
Baum, R. P., Kulkarni, H., & Carreras, C. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.01.002 · Cited by 134
Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green, M. A., Klippenstein, D. L., & Tennison, J. R. (1988) · PubMed · Cited by 131
Improved in vivo stability and tumor targeting of bismuth-labeled antibody.
Ruegg, C. L., Anderson-Berg, W. T., Brechbiel, M. W., Mirzadeh, S., Gansow, O. A., & Strand, M. (1990) · PubMed · Cited by 130
Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.
Green, M. A., Mathias, C. J., Welch, M. J., et al. (1990) · PubMed · Cited by 130
A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases
Liepe, K., & Kotzerke, J. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e32825a6adc · Cited by 120
Engineered liposomes for potential alpha-particle therapy of metastatic cancer.
Sofou, S., Thomas, J. L., Lin, H. Y., McDevitt, M. R., Scheinberg, D. A., & Sgouros, G. (2004) · PubMed · Cited by 119
Comparative studies of Cu-64-ATSM and C-11-Acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats
Fujibayashi, Y., Cutler, C., Anderson, C. J., Mccarthy, D. W., Jones, L. A., Sharp, T. L., Yonekura, Y., & Welch, M. J. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00049-3 · Cited by 116
Self-citation
The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticals
Donnelly, P. S. (2011) · Dalton Transactions · doi:10.1039/c0dt01075h · Cited by 112
Vascular Imaging of Solid Tumors in Rats with a Radioactive Arsenic-Labeled Antibody that Binds Exposed Phosphatidylserine
Jennewein, M., Lewis, M. A., Zhao, D., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1516 · Cited by 110
213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model
Norenberg, J. P., Krenning, B. J., Konings, I. R. H. M., Kusewitt, D. F., Nayak, T. K., Anderson, T. L., de Jong, M., Garmestani, K., Brechbiel, M. W., & Kvols, L. K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1264 · Cited by 105
Phase I Study of Samarium-153 Lexidronam With Docetaxel in Castration-Resistant Metastatic Prostate Cancer
Morris, M. J., Pandit-Taskar, N. D., Carrasquillo, J. A., Divgi, C. R., Slovin, S. F., Kelly, W. K., Rathkopf, D. E., Gignac, G. A., Solit, D. B., Schwartz, L. H., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.4164 · Cited by 101
Radiochemical purification of no-carrier-added scandium-47 for radioimmunotherapy
Kolsky, K. L., Joshi, V. N., Mausner, L. F., & Srivastava, S. C. (1998) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(98)00016-5 · Cited by 100
Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
Lewis, J. S., Herrero, P., Sharp, T. L., Engelbach, J. A., Fujibayashi, Y., Laforest, R. A., Kovács, A. D., Gropler, R. J., & Welch, M. J. (2002) · PubMed · Cited by 97
Three-Dimensional Imaging-Based Radiobiological Dosimetry
Sgouros, G., Frey, E. C., Wahl, R. L., He, B., Prideaux, A. R., & Hobbs, R. F. (2008) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2008.05.008 · Cited by 93
Paving the Way to Personalized Medicine: Production of Some Promising Theragnostic Radionuclides at Brookhaven National Laboratory
Srivastava, S. C. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.12.004 · Cited by 89
In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. a new somatostatin analog with improved target tissue uptake
Lewis, J. S., Srinivasan, A., Schmidt, M. A., & Anderson, C. J. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(98)00105-x · Cited by 89
Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
Horak, E. M., Hartmann, F., Garmestani, K., Wu, C., Brechbiel, M. W., Gansow, O. A., Landolfi, N. F., & Waldmann, T. A. (1997) · PubMed · Cited by 86
Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy
Khan, M. K., Minc, L. D., Nigavekar, S. S., et al. (2008) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.11.005 · Cited by 85
Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates
Li, M., & Meares, C. F. (1993) · Bioconjugate Chemistry · doi:10.1021/bc00022a005 · Cited by 85
Samarium-153 and Lutetium-177 Chelation Properties of Selected Macrocyclic and Acyclic Ligands
Stimmel, J. B., & Kull, F. C. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00151-0 · Cited by 79
Somatostatin-receptor-targeted α-emitting 213Bi is therapeutically more effective than β−-emitting 177Lu in human pancreatic adenocarcinoma cells
Nayak, T. K., Norenberg, J. P., Anderson, T. L., Prossnitz, E. R., Stabin, M. G., & Atcher, R. W. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.11.006 · Cited by 76
Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias, C. J., Welch, M. J., Raichle, M. E., Mintun, M. A., Lich, L. L., McGuire, A. H., Zinn, K. R., John, E. K., & Green, M. A. (1990) · PubMed · Cited by 71
Uptake and efflux of copper-64 in Menkes'-disease and normal continuous lymphoid cell lines
Herd, S. M., Camakaris, J., Christofferson, R., et al. (1987) · Biochemical Journal · doi:10.1042/bj2470341 · Cited by 70
Hemibody irradiation (HBI) for metastatic bone pain in two histologically distinct groups of patients
Hoskin, P., Ford, H. T., & Harmer, C. (1989) · Clinical Oncology · doi:10.1016/s0936-6555(89)80037-8 · Cited by 66
44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?
Koumarianou, E., Loktionova, N. S., Fellner, M., Roesch, F., Thews, O., Pawlak, D., Archimandritis, S. C., & Mikołajczak, R. (2012) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2012.08.004 · Cited by 61
Treatment of hepatocellular carcinoma with intra-arterial injection of radionuclides
Raoul, J., Boucher, É., Rolland, Y., & Garin, É. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.202 · Cited by 59
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.
Breitz, H. B., Wendt, R. E., Stabin, M., Shen, S., Erwin, W. D., Rajendran, J. G., Eary, J. F., Durack, L. D., Delpassand, E. S., Martin, W., et al. (2006) · PubMed · Cited by 59
Structural chemistry of Sc(III): an overview
Meehan, P. R., Aris, D. R., & Willey, G. R. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00214-8 · Cited by 55
Stability constants of metal complexes of macrocyclic ligands with pendant donor groups
Martell, A. E., Motekaitis, R. J., Clarke, E. T., Delgado, R., Sun, Y., & Ma, R. (1996) · Supramolecular chemistry · doi:10.1080/10610279608032555 · Cited by 55
Comparative cellular catabolism and retention of astatine-, bismuth-, and lead-radiolabeled internalizing monoclonal antibody.
Yao, Z., Garmestani, K., Wong, K. J., Park, L. S., Dadachova, E., Yordanov, A. T., Waldmann, T. A., Eckelman, W. C., Paik, C. H., & Carrasquillo, J. A. (2001) · PubMed · Cited by 51
The use of 212Pb-labeled monoclonal antibody in the treatment of murine erythroleukemia
Ruble, G., Wu, C., Squire, R. A., Gansow, O. A., & Strand, M. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02119-1 · Cited by 49
A Rare Earth-DOTA-Binding Antibody: Probe Properties and Binding Affinity across the Lanthanide Series
Corneillie, T. M., Whetstone, P. A., Fisher, A. J., & Meares, C. F. (2003) · Journal of the American Chemical Society · doi:10.1021/ja029363k · Cited by 44
Chemical and biological evaluation of scandium(III)-polyaminopolycarboxylate complexes as potential PET agents and radiopharmaceuticals
Huclier‐Markai, S., Sabatié‐Gogova, A., Ribet, S., Kubíček, V., Paris, M., Vidaud, C., Hermann, P., & Cutler, C. (2011) · Radiochimica Acta · doi:10.1524/ract.2011.1869 · Cited by 43
Self-citation
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A”-C595
Qu, C. F., Song, Y., Rizvi, S. M., Li, Y., Smith, R. C., Perkins, A. C., Morgenstern, A., Brechbiel, M. W., & Allen, B. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.8.1892 · Cited by 42
Pharmacokinetics and bioactivity of 1,4,7,10-tetra-azacylododecane off',N'',N'''-tetraacetic acid (DOTA)-bismuth-conjugated anti-Tac antibody for alpha-emitter (212Bi) therapy.
Junghans, R. P., Dobbs, D., Brechbiel, M. W., Mirzadeh, S., Raubitschek, A. A., Gansow, O. A., & Waldmann, T. A. (1993) · PubMed · Cited by 41
Pretargeted α Emitting Radioimmunotherapy Using 213Bi 1,4,7,10-Tetraazacyclododecane-N,N′,N″,N‴-Tetraacetic Acid-Biotin
Yao, Z., Zhang, M., Garmestani, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0171 · Cited by 41
Tissue dosimetry of liposome-radionuclide complexes for internal radiotherapy: toward liposome-targeted therapeutic radiopharmaceuticals.
Kostarelos, K., & Emfietzoglou, D. (2000) · PubMed · Cited by 40
Outpatient therapeutic nuclear oncology
Turner, J. H. (2012) · Annals of Nuclear Medicine · doi:10.1007/s12149-011-0566-z · Cited by 33
Multiple myeloma: Monoclonal antibodies-based immunotherapeutic strategies and targeted radiotherapy
Chatterjee, M., Chakraborty, T., & Tassone, P. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.02.016 · Cited by 28
Synthesis and in Vitro Evaluation of a Rhenium-Cyclized Somatostatin Derivative Series
Hennkens, H. M., Junnotula, S., Ma, L., Gallazzi, F., Lewis, M. R., & Jurisson, S. S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701056x · Cited by 24
Self-citation
The in vivo generator for radioimmunotherapy
Mausner, L. F., Straub, R. F., & Srivastava, S. C. (1989) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.25802601213 · Cited by 23
Dosimetry in molecular nuclear therapy
Wierts, R., de Pont, C. D. J. M., Brans, B. T., Mottaghy, F. M., & Kemerink, G. J. (2011) · Methods · doi:10.1016/j.ymeth.2011.09.016 · Cited by 22
Antibody-based treatment of acute myeloid leukaemia
Mulford, D. A., & Jurcic, J. G. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.1.95 · Cited by 22

Matching chelators to radiometals for radiopharmaceuticals
Price, E. W., & Orvig, C. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60304k · Cited by 1,018
Compound Copper Chalcogenide Nanocrystals
Coughlan, C., Ibáñez, M., Dobrozhan, O., Singh, A., Cabot, A., & Ryan, K. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00376 · Cited by 930
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
Dash, A., Pillai, M. R. A., & Knapp, F. F. (2015) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-014-0315-z · Cited by 386
Radioactive Transition Metals for Imaging and Therapy
Boros, E., & Packard, A. B. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00281 · Cited by 299
Tumour targeting with radiometals for diagnosis and therapy
Ramogida, C. F., & Orvig, C. (2013) · Chemical Communications · doi:10.1039/c3cc41554f · Cited by 255

See all 395

Authors: Cutler, C. S., Hennkens, H. M., Sisay, N., Huclier-Markai, S., & Jurisson, S. S.
Venue: Chemical Reviews
Publisher: American Chemical Society (ACS)
Published: 2012-11-30
Volume: 113
Issue: 2
Pages: 858-883
ISSN: 0009-2665 (ISSN-L)
1520-6890
DOI: 10.1021/cr3003104
OpenAlex: W1969694608
Cited by: 395
References: 86
FWCI: 3.96
Type: journal article
Language: en
Open access: closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Radiometals for Combined Imaging and Therapy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources